Wei-Xiang SIN
Wei-Xiang Sin is a Research Scientist in the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) program at the Singapore-MIT Alliance for Research and Technology Centre (SMART). A molecular immunologist by training, he brings extensive academic and industry experience across the cell and gene therapy pipeline, from GMP-certified lentiviral vector manufacturing to immune cell therapy characterization and process analytics.
Wei-Xiang earned his PhD through the inaugural Singapore Immunology Network (SIgN)-NTU Joint Immunology PhD Programme at A*STAR, and completed postdoctoral training at the Genome Institute of Singapore (GIS) and the Institute of Molecular and Cell Biology (IMCB), focusing on synthetic biology and translational immunology. Prior to SMART, he gained industry experience at a GMP-certified CDMO specialising in clinical-grade lentiviral vector production for cell and gene therapies.
Beyond research, Wei-Xiang is actively engaged in biotech entrepreneurship and innovation, having participated in the SMART Innovation Centre’s Venture Exploration, Design, and Execution programmes, and completed a Graduate Certificate in Intellectual Property and Innovation Management. Wei-Xiang currently serves as Treasurer and Head of Communications at Biotech Connection Singapore (BCS), having previously held the role of Communications Lead, where he contributes to thought leadership, ecosystem engagement, and community building.
Biotech Connection Singapore
Biotech Connection Singapore (BCS) is part of an international network of non-profit organizations, that aims to promote the transfer of ideas from theory to real world applications by providing a platform for fostering interaction between academia, industry and businesses.
